Successful Erlotinib Treatment for a Patient with Gefitinib-Related Hepatotoxicity and Lung Adenocarcinoma Refractory to Intermittently Administered Gefitinib
Case Reports in Pulmonology · 2011
DOI: 10.1155/2011/812972 ↗Kurz gefasst
Fallbericht in der Zeitschrift Case Reports in Pulmonology, 2011. Verfasst von Tatsuya Nagano und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Respiratory Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine, 7-5-1 Kusunokicho, Chuo-ku, Kobe, Hyo…. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).
Abstract (Originalsprache)
A 73-year-old Japanese man was histologically diagnosed with lung adenocarcinoma harboring an exon 19 deletion in the epidermal growth factor receptor. The patient was treated with gefitinib for 6 weeks until he developed substantially elevated hepatic enzyme levels that resulted in the discontinuation of gefitinib. Gefitinib was reintroduced with an intermittent treatment schedule after the transaminase levels normalized, but the patient's enzyme levels rose again, and the cancer progressed. Gefitinib was eventually replaced with erlotinib. There was stable disease for 7 weeks without any signs of liver toxicity. Thus, erlotinib may be a beneficial and well-tolerated treatment option for patients with gefitinib-related hepatotoxicity.
Autor:innen und Institutionen
- Division of Respiratory Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine, 7-5-1 Kusunokicho, Chuo-ku, Kobe, Hyogo 650-0017, Japan.
Zitieren
APA
Nagano, T., Kotani, Y., Kobayashi, K., Katsurada, M., Hatakeyama, Y., Hori, S., Tamura, D., Kasai, D., Funada, Y., & Nishimura, Y. (2011). Successful Erlotinib Treatment for a Patient with Gefitinib-Related Hepatotoxicity and Lung Adenocarcinoma Refractory to Intermittently Administered Gefitinib. Case Reports in Pulmonology. https://doi.org/10.1155/2011/812972
Vancouver
Nagano T, Kotani Y, Kobayashi K, Katsurada M, Hatakeyama Y, Hori S, et al. Successful Erlotinib Treatment for a Patient with Gefitinib-Related Hepatotoxicity and Lung Adenocarcinoma Refractory to Intermittently Administered Gefitinib. Case Reports in Pulmonology. 2011. doi:10.1155/2011/812972
BibTeX
@article{Nagano2011,
author = {Nagano, Tatsuya and Kotani, Yoshikazu and Kobayashi, Kazuyuki and Katsurada, Masahiro and Hatakeyama, Yukihisa and Hori, Suya and Tamura, Daisuke and Kasai, Daisuke and Funada, Yasuhiro and Nishimura, Yoshihiro},
title = {Successful Erlotinib Treatment for a Patient with Gefitinib-Related Hepatotoxicity and Lung Adenocarcinoma Refractory to Intermittently Administered Gefitinib},
journal = {Case Reports in Pulmonology},
year = {2011},
doi = {10.1155/2011/812972}
}
EUVIMED